Murphy Pohlad Asset Management’s Merck MRK Stock Holding History

Murphy Pohlad Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19M	Hold	17,023	–	–	0.76%	45
2026 Q1	$2.05M	Buy	17,023 +195	+1%	+$22.5K	0.73%	47
2025 Q4	$1.77M	Sell	16,828 -200	-1%	-$18.8K	0.68%	53
2025 Q3	$1.43M	Sell	17,028 -5,500	-24%	-$453K	0.56%	58
2025 Q2	$1.78M	Sell	22,528 -2,880	-11%	-$229K	0.75%	51
2025 Q1	$2.28M	Buy	25,408 +200	+0.8%	+$18.7K	0.97%	44
2024 Q4	$2.51M	Hold	25,208	–	–	1.08%	40
2024 Q3	$2.86M	Sell	25,208 -808	-3%	-$96K	1.19%	38
2024 Q2	$3.22M	Sell	26,016 -120	-0.5%	-$15.5K	1.39%	30
2024 Q1	$3.45M	Sell	26,136 -85	-0.3%	-$10.5K	1.35%	31
2023 Q4	$2.86M	Sell	26,221 -370	-1%	-$38.4K	1.18%	35
2023 Q3	$2.74M	Hold	26,591	–	–	1.2%	33
2023 Q2	$3.07M	Sell	26,591 -970	-4%	-$110K	1.32%	32
2023 Q1	$2.93M	Sell	27,561 -2,070	-7%	-$223K	1.22%	37
2022 Q4	$3.29M	Buy	29,631 +118	+0.4%	+$12.1K	1.35%	30
2022 Q3	$2.54M	Sell	29,513 -440	-1%	-$39.3K	1.18%	38
2022 Q2	$2.73M	Hold	29,953	–	–	1.2%	37
2022 Q1	$2.46M	Sell	29,953 -4,590	-13%	-$362K	0.99%	43
2021 Q4	$2.65M	Sell	34,543 -430	-1%	-$34.2K	1.04%	39
2021 Q3	$2.63M	Sell	34,973 -3,610	-9%	-$275K	1.07%	40
2021 Q2	$3M	Sell	38,583 -2,696	-7%	-$201K	1.21%	33
2021 Q1	$3.04M	Buy	41,279 +9,558	+30%	+$705K	1.32%	34
2020 Q4	$2.48M	Buy	31,721 +2,342	+8%	+$179K	1.23%	36
2020 Q3	$2.33M	Buy	29,379 +708	+2%	+$55.5K	1.23%	31
2020 Q2	$2.12M	Buy	28,671 +2,890	+11%	+$218K	1.18%	37
2020 Q1	$1.89M	Buy	25,781 +12,241	+90%	+$962K	1.29%	31
2019 Q4	$1.18M	Buy	13,540 +1,290	+11%	+$106K	0.64%	52
2019 Q3	$983K	Hold	12,250	–	–	0.6%	50
2019 Q2	$980K	Sell	12,250 -88	-0.7%	-$6.74K	0.59%	56
2019 Q1	$979K	Sell	12,338 -63	-0.5%	-$4.71K	0.59%	54
2018 Q4	$904K	Sell	12,401 -283	-2%	-$20K	0.63%	51
2018 Q3	$858K	Sell	12,684 -314	-2%	-$20K	0.53%	59
2018 Q2	$752K	Sell	12,998 -310	-2%	-$17.5K	0.5%	57
2018 Q1	$691K	Buy	13,308 +357	+3%	+$19.3K	0.48%	57
2017 Q4	$695K	Buy	12,951 +1,388	+12%	+$76.9K	0.46%	60
2017 Q3	$706K	Hold	11,563	–	–	0.49%	56
2017 Q2	$707K	Hold	11,563	–	–	0.52%	53
2017 Q1	$701K	Sell	11,563 -1,866	-14%	-$113K	0.52%	55
2016 Q4	$754K	Sell	13,429 -812	-6%	-$47.5K	0.55%	58
2016 Q3	$848K	Hold	14,241	–	–	0.63%	54
2016 Q2	$782K	Buy	14,241 +387	+3%	+$20.6K	0.58%	57
2016 Q1	$699K	Buy	13,854 +2,746	+25%	+$134K	0.53%	60
2015 Q4	$559K	Buy	11,108 +1,693	+18%	+$85.4K	0.44%	65
2015 Q3	$443K	Buy	9,415 +2,190	+30%	+$116K	0.36%	71
2015 Q2	$392K	Hold	7,225	–	–	0.3%	73
2015 Q1	$396K	Hold	7,225	–	–	0.3%	71
2014 Q4	$391K	Hold	7,225	–	–	0.28%	75
2014 Q3	$408K	Hold	7,225	–	–	0.32%	74
2014 Q2	$398K	Hold	7,225	–	–	0.31%	71
2014 Q1	$391K	Hold	7,225	–	–	0.32%	70
2013 Q4	$345K	Sell	7,225 -210	-3%	-$9.6K	0.28%	71
2013 Q3	$337K	Hold	7,435	–	–	0.3%	67
2013 Q2	$329K	Buy	+7,435	New	+$332K	0.3%	66

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Murphy Pohlad Asset Management's MRK Position: Q2 2026 in Review

Murphy Pohlad Asset Management held its Merck (MRK) position steady in Q2 2026 at 17,023 shares worth $2.19M. The position accounts for 0.76% of the portfolio, ranked #45.

Murphy Pohlad Asset Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.45M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Murphy Pohlad Asset Management held 17,023 shares of Merck worth $2.19M as of Q2 2026.
Murphy Pohlad Asset Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.76% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #45 holding.
Murphy Pohlad Asset Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Murphy Pohlad Asset Management's Merck position peaked at $3.45M in Q1 2024.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.